“peripheral-artery-disease” Archives

Entry Author Date Location
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
New San Diego Biotech Charts Stem-Cell Therapies for Heart Disease 02/19/14 San Diego
Abbott to Acquire Medical Device Startup Idev Technologies 07/26/13 Texas
Pathway Medical Grinds It Out, Seeks Profit Formula, Three Years After FDA Approval 06/08/11 Seattle
Pervasis in “Advanced” Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says 02/01/11 Boston
Aastrom Gets FDA Fast Track Status, Gears Up for Pivotal Study of Cell Therapy 10/18/10 Detroit Ann Arbor
Covidien to Buy Ev3 for $2.6B 06/01/10 Boston
Pathway Medical Learns Lessons During Tougher Than Expected First Year on Market 10/20/09 Seattle
Minnow Medical Aims to Commercialize Improved Device for Treating Peripheral Artery Disease 09/09/09 San Diego
Genzyme Gene Therapy Fails To Help People with Leg Disease Walk Longer 03/31/09 Boston
Pathway Medical Raises $40M for Device to Clear Out Blocked Leg Arteries 03/26/09 Seattle
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days 03/25/09 Boston
Pathway Medical Tool Shows Early Signs of Emerging as “Real Winner” 02/02/09 Seattle
Pathway Medical, With FDA Clearance in Hand, Starts Selling Device for Wiping Out Blockages in Leg Arteries 09/05/08 Seattle
Pathway Wins FDA Approval To Sell Blocked-Artery Buster 07/21/08 Seattle
Page 1 of 1